Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

Shubham Pant(The University of Texas MD Anderson Cancer Center), Martin Schüler, Gopa Iyer(Memorial Sloan Kettering Cancer Center), Olaf Witt(German Cancer Research Center), Toshihiko Doi(National Cancer Center Hospital East), Shukui Qin(Nanjing University of Chinese Medicine), Josep Tabernero(Vall d'Hebron Institut de Recerca), David A. Reardon(Harvard University), Christophe Massard(Inserm), Anna Minchom(Royal Marsden NHS Foundation Trust), Iwona Ługowska(Centrum Onkologii), Omar Carranza(Hospital Privado de Comunidad), Dirk Arnold(Asklepios Klinik Altona), Martin Gutierrez(Hackensack University Medical Center), Helen Winter(At Bristol), Kim Stuyckens(Janssen (Belgium)), Lauren Crow(Janssen (United States)), Saltanat Najmi(Janssen (United States)), Constance Hammond(Janssen (United States)), Shibu Thomas(Janssen (United States)), Ademi Santiago-Walker(Janssen (United States)), Spyros Triantos(Janssen (United States)), Hussein Sweiti(Janssen (United States)), Yohann Loriot(Inserm), Omar Carranza(Hospital Privado de Comunidad), Martin Alberto Greco, Jim Coward, Anthony M. Joshua, Christos S. Karapetis, Christopher D. Hart, Alison Y. Zhang, Hans Prenen, Jean‐Charles Goeminne, Jean‐Pascal Machiels, Sylvie Rottey, Marcelo Corassa, Graziela Zibetti Dal Molin, Katsuki Arima Tiscoski, Denis L. Jardim, Milena Perez Mak, Wei Fu(Janssen (United States)), Herui Yao, Jing Huang, Haiping Jiang, Shukui Qin(Nanjing University of Chinese Medicine), Baoshi Chen, Dong Yan, Yu Yang, Yohann Loriot(Inserm), Christophe Le Tourneau(Inserm), Nicolas Penel, Sébastien Salas, Jean‐Yves Blay, Pierre-Emmanuel Brachet, Xavier Durando(Université Clermont Auvergne), Sheik Emambux, Alain Ravaud, Gunnar Folprecht, Dirk Arnold(Asklepios Klinik Altona), Martin Schüler, Marit Ahrens, Alexander Golf, Georg Martin Haag, Florian Lordick, Alexander Desuki, Marina Elena Cazzaniga, Fortunato Ciardiello, Michèle Milella, Takafumi Koyama, Yoshiki Hirooka, Wataru Okamoto, Kenjiro Aogi, Yasutoshi Kuboki, Jung-Yun Lee, Sung‐Bae Kim(Janssen (Belgium)), Myung‐Ju Ahn, Jong Hee Chang, Yongman Kim(Janssen (Belgium)), Do‐Hyun Nam(Royal Marsden NHS Foundation Trust), Jaesung Park, Iwona Ługowska(Centrum Onkologii), Luis Paz‐Ares, Víctor Moreno, Andrés Cervantes, Mariona Calvo, Alejandro Falcón, Antonio González, Josep Tabernero(Vall d'Hebron Institut de Recerca), A. Martinez Bueno, Javier García-Corbacho, Federico Longo, Chia‐Jui Yen, Jen‐Shi Chen, Ming‐Feng Hou, Yee Chao, Kun‐Ming Rau, Tai‐Jan Chiu, Yin‐Hsun Feng, Chih‐Hung Hsu, Wen‐Tsung Huang, Kuan-Ming Lai, Su‐Peng Yeh, Daniel H. Palmer, Anna Minchom(Royal Marsden NHS Foundation Trust), Helen Winter(At Bristol), Liam Welsh, Ruth Plummer, Gopa Iyer(Memorial Sloan Kettering Cancer Center), Martin Gutierrez(Hackensack University Medical Center), Mehmet Asım Bilen, Edward Arrowsmith(The University of Texas MD Anderson Cancer Center), Shubham Pant(The University of Texas MD Anderson Cancer Center), David R. Spigel, Dan P. Zandberg, Deborah B. Doroshow, Christine Lu‐Emerson, Mehdi M. Moezi, Scott Paulson(Harvard University), David A. Reardon(Harvard University), Patrick J. Ward, Jorge Chaves, Claud Grigg(Janssen (United States)), Atif Hussein, Sudhir Manda, Michael Monticelli, Rubina Qamar, Stephen Richey(Harvard University), David Tamura, Sharon Wilks
The Lancet Oncology
August 1, 2023
Cited by 194Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis